|
|
Article: Research and Markets: Per Capita Spending on Pharmaceuticals in Egypt Will Continue to be Relatively Low Compared to its Arab Neighbours, at US$46 by 2013.
- Article from:
- Business Wire
- Article date:
- April 16, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/05ca37/egypt_pharmaceutic) has announced the addition of the "Egypt Pharmaceuticals and Healthcare Report Q1 2009" report to their offering.
BMI's Egypt Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Egypt's pharmaceuticals and healthcare industry.
In this quarter's report, BMI has extended its forecasts for the Egyptian pharmaceutical sector from 2009- 2013. Overall, we expect the total drug market expenditure to increase from US$2.3bn 2008 to US$3.8bn by 2013. In our view, one of the main drivers for growth will be a ...